Literature DB >> 31235907

Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes.

Sarah H Shahmoradian1,2, Amanda J Lewis1, Christel Genoud3, Jürgen Hench4, Tim E Moors5, Paula P Navarro1, Daniel Castaño-Díez1, Gabriel Schweighauser4, Alexandra Graff-Meyer3, Kenneth N Goldie1, Rosmarie Sütterlin1, Evelien Huisman5, Angela Ingrassia5, Yvonne de Gier5, Annemieke J M Rozemuller6, Jing Wang1, Anne De Paepe7, Johannes Erny8, Andreas Staempfli8, Joerg Hoernschemeyer8, Frederik Großerüschkamp9, Daniel Niedieker9, Samir F El-Mashtoly9, Marialuisa Quadri10, Wilfred F J Van IJcken11, Vincenzo Bonifati10, Klaus Gerwert9, Bernd Bohrmann12, Stephan Frank4, Markus Britschgi12, Henning Stahlberg13, Wilma D J Van de Berg14, Matthias E Lauer15.   

Abstract

Parkinson's disease, the most common age-related movement disorder, is a progressive neurodegenerative disease with unclear etiology. Key neuropathological hallmarks are Lewy bodies and Lewy neurites: neuronal inclusions immunopositive for the protein α-synuclein. In-depth ultrastructural analysis of Lewy pathology is crucial to understanding pathogenesis of this disease. Using correlative light and electron microscopy and tomography on postmortem human brain tissue from Parkinson's disease brain donors, we identified α-synuclein immunopositive Lewy pathology and show a crowded environment of membranes therein, including vesicular structures and dysmorphic organelles. Filaments interspersed between the membranes and organelles were identifiable in many but not all α-synuclein inclusions. Crowding of organellar components was confirmed by stimulated emission depletion (STED)-based super-resolution microscopy, and high lipid content within α-synuclein immunopositive inclusions was corroborated by confocal imaging, Fourier-transform coherent anti-Stokes Raman scattering infrared imaging and lipidomics. Applying such correlative high-resolution imaging and biophysical approaches, we discovered an aggregated protein-lipid compartmentalization not previously described in the Parkinsons' disease brain.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31235907     DOI: 10.1038/s41593-019-0423-2

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  217 in total

Review 1.  GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies.

Authors:  Parker H Johnson; Neal J Weinreb; James C Cloyd; Paul J Tuite; Reena V Kartha
Journal:  Mol Genet Metab       Date:  2019-10-23       Impact factor: 4.797

Review 2.  Deubiquitylating enzymes in neuronal health and disease.

Authors:  Fatima Amer-Sarsour; Alina Kordonsky; Yevgeny Berdichevsky; Gali Prag; Avraham Ashkenazi
Journal:  Cell Death Dis       Date:  2021-01-22       Impact factor: 8.469

3.  Alpha-synuclein: prion or prion-like?

Authors:  Rehana K Leak; Matthew P Frosch; Thomas G Beach; Glenda M Halliday
Journal:  Acta Neuropathol       Date:  2019-08-12       Impact factor: 17.088

Review 4.  Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration.

Authors:  Fred Yeboah; Tae-Eun Kim; Anke Bill; Ulf Dettmer
Journal:  Neurobiol Dis       Date:  2019-07-24       Impact factor: 5.996

Review 5.  Parkinson's disease: proteinopathy or lipidopathy?

Authors:  Saranna Fanning; Dennis Selkoe; Ulf Dettmer
Journal:  NPJ Parkinsons Dis       Date:  2020-01-03

6.  α-Synuclein Seeding Assay Using Cultured Cells.

Authors:  Jun Ogata; Daisaku Takemoto; Shotaro Shimonaka; Yuzuru Imai; Nobutaka Hattori
Journal:  Methods Mol Biol       Date:  2021

Review 7.  α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome.

Authors:  Rui Wang; Hongyang Sun; Haigang Ren; Guanghui Wang
Journal:  Sci China Life Sci       Date:  2020-07-15       Impact factor: 6.038

8.  Fragmentation of the Golgi complex of dopaminergic neurons in human substantia nigra: New cytopathological findings in Parkinson's disease.

Authors:  Mónica Tomás; Emma Martínez-Alonso; Narcisa Martínez-Martínez; Mireia Cara-Esteban; José A Martínez-Menárguez
Journal:  Histol Histopathol       Date:  2020-10-20       Impact factor: 2.303

Review 9.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

Review 10.  Endosomal sorting pathways in the pathogenesis of Parkinson's disease.

Authors:  Lindsey A Cunningham; Darren J Moore
Journal:  Prog Brain Res       Date:  2020-03-16       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.